Session Tracks

This session will explore the various mechanisms employed by pathogenic yeasts to establish infections in host organisms. Discussions will focus on virulence factors and their roles in pathogenicity.

This track will address the growing concern of antifungal resistance in pathogenic yeasts, examining the underlying genetic and environmental factors. Participants will discuss innovative strategies to combat resistance and improve treatment outcomes.

This session will delve into the complex interactions between pathogenic yeasts and their hosts, highlighting both the host immune response and yeast adaptation mechanisms. Insights into these interactions are crucial for developing effective therapeutic strategies.

This track will focus on the application of genomic technologies to understand the pathogenicity of yeast species. Researchers will present findings on genetic determinants of virulence and their implications for disease management.

This session will examine the clinical aspects of diagnosing and managing fungal infections caused by pathogenic yeasts. Emphasis will be placed on mycological diagnostics and the role of clinical microbiology in patient care.

This track will highlight recent advancements in the development of antifungal agents targeting pathogenic yeasts. Discussions will include novel compounds, mechanisms of action, and clinical trial outcomes.

This session will provide an overview of the physiological processes in pathogenic yeasts that contribute to their survival and virulence. Understanding these biological aspects is essential for identifying therapeutic targets.

This track will focus on the epidemiological trends of yeast infections, including prevalence, risk factors, and population dynamics. Participants will discuss the implications of these trends for public health and disease control.

This session will explore the regulatory mechanisms governing virulence gene expression in pathogenic yeasts. Insights gained from this research can inform strategies to mitigate fungal pathogenesis.

This track will present various experimental models used to study fungal pathogenesis in yeasts. Researchers will share findings that elucidate the mechanisms of disease and host responses.

This session will discuss potential therapeutic targets for controlling diseases caused by pathogenic yeasts. Emphasis will be placed on innovative approaches to treatment and prevention.